Medi Caps Limited Stock Price Today (NSE: MEDICAPQ)
Fundamental Score
Medi Caps Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Medi Caps Limited share price today is ₹35.22, up +14.57% on NSE/BSE as of 10 September 2026. Medi Caps Limited (MEDICAPQ) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹33.49 (Cr). The 52-week high for MEDICAPQ share price is ₹36.80 and the 52-week low is ₹20.33. The company has a Return on Equity (ROE) of -2.61% and a debt-to-equity ratio of 0.00.
Medi Caps Limited Share Price Chart — NSE/BSE Historical Performance
Medi Caps Limited share price chart: -0.85% return over the past month. 52-week high ₹36.80, 52-week low ₹20.33.
Medi Caps Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹32.79 | ₹36.80 | ₹29.96 | ₹35.22 | 4.94L (Cr) | |
| ₹27.72 | ₹30.74 | ₹26.99 | ₹30.74 | 1.01L (Cr) | |
| ₹27.00 | ₹27.90 | ₹25.00 | ₹25.62 | 772.00 (Cr) | |
| ₹26.94 | ₹26.94 | ₹24.00 | ₹26.90 | 2.93K (Cr) | |
| ₹26.90 | ₹26.90 | ₹25.16 | ₹26.29 | 1.65K (Cr) | |
| ₹26.43 | ₹27.00 | ₹24.00 | ₹25.08 | 2.75K (Cr) | |
| ₹23.80 | ₹27.29 | ₹23.80 | ₹26.70 | 4.28K (Cr) | |
| ₹26.06 | ₹27.00 | ₹25.21 | ₹26.99 | 1.87K (Cr) | |
| ₹26.03 | ₹26.50 | ₹26.03 | ₹26.49 | 101.00 (Cr) | |
| ₹25.58 | ₹26.50 | ₹25.00 | ₹25.91 | 1.31K (Cr) |
Medi Caps Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹26.06 | ₹36.80 | ₹23.80 | ₹35.22 | +35.15% | |
| ₹24.65 | ₹28.40 | ₹20.33 | ₹26.49 | +7.46% | |
| ₹26.59 | ₹28.36 | ₹23.88 | ₹26.82 | +0.86% | |
| ₹28.50 | ₹33.00 | ₹25.00 | ₹26.59 | -6.70% | |
| ₹26.01 | ₹36.00 | ₹26.00 | ₹28.56 | +9.80% | |
| ₹22.66 | ₹31.97 | ₹22.66 | ₹28.12 | +24.10% | |
| ₹24.61 | ₹28.62 | ₹21.00 | ₹23.20 | -5.73% | |
| ₹26.56 | ₹27.45 | ₹21.02 | ₹24.61 | -7.34% | |
| ₹31.20 | ₹36.19 | ₹25.70 | ₹26.90 | -13.78% | |
| ₹34.00 | ₹35.99 | ₹28.13 | ₹31.23 | -8.15% | |
| ₹38.22 | ₹42.99 | ₹32.31 | ₹33.51 | -12.32% | |
| ₹38.67 | ₹44.70 | ₹34.32 | ₹39.00 | +0.85% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Medi Caps Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Medi Caps Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of MEDICAPQ across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Robust Profit Growth (76.74%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Healthy Liquidity Position (Current Ratio: 17.25)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Balanced Promoter Holding (51.36%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
8 factors identified
Below-Average Return on Equity (-2.61%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-2.59%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (2.19%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Revenue Contraction (-50.50%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (-26.34% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Interest Coverage (-302.00x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Limited Institutional Interest (FII+DII: 0.02%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Medi Caps Limited vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Medi Caps Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Medi Caps LimitedMedi Caps Limit...Selected✓ MEDICAPQ • 523144 | 18.5/100 | ₹35.22₹35 | ₹33.49₹33.49 | — — | -2.61%Poor -2.61% Poor | -2.59%Poor -2.59% Poor | 0.00Excellent 0.0 Excellent | — — | -26.34%Poor -26.34% Poor | 0.00% |
Sun Pharmaceutical Industries LimitedSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1876.50₹1877 | ₹450228.65₹450228.65 | 37.23Average 37.2 Average | 14.74%Average 14.74% Average | 19.31%Good 19.31% Good | 0.05Excellent 0.0 Excellent | 31.64%Excellent 31.64% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divi's Laboratories LimitedDivi's Laborato... DIVISLAB • 532488 | 56.3/100 | ₹9467.50₹9468 | ₹250888.75₹250888.75 | 85.90Average 85.9 Average | 16.19%Good 16.19% Good | 20.38%Excellent 20.38% Excellent | 0.00Excellent 0.0 Excellent | 5.29%Good 5.29% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LimitedTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹4939.50₹4940 | ₹167182.32₹167182.32 | 78.91Average 78.9 Average | 27.07%Excellent 27.07% Excellent | 14.09%Average 14.09% Average | 1.76Average 1.8 Average | 11.56%Good 11.56% Good | 11.80%Good 11.80% Good | 0.76% |
Zydus Lifesciences LimitedZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1138.70₹1139 | ₹113642.26₹113642.26 | 25.38Average 25.4 Average | 19.74%Good 19.74% Good | 21.77%Excellent 21.77% Excellent | 0.43Excellent 0.4 Excellent | 18.76%Excellent 18.76% Excellent | 12.45%Good 12.45% Good | 0.09% |
Cipla LimitedCipla Limited... CIPLA • 500087 | 40.2/100 | ₹1371.90₹1372 | ₹110828.94₹110828.94 | 32.87Average 32.9 Average | 11.82%Average 11.82% Average | 15.67%Good 15.67% Good | 0.01Excellent 0.0 Excellent | 10.03%Good 10.03% Good | 8.01%Good 8.01% Good | 0.90% |
Laurus Labs LimitedLaurus Labs Lim... LAURUSLABS • 540222 | 34.1/100 | ₹1941.10₹1941 | ₹104867.93₹104867.93 | 95.81Average 95.8 Average | 18.19%Good 18.19% Good | 21.35%Excellent 21.35% Excellent | 0.45Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Aurobindo Pharma LimitedAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1683.00₹1683 | ₹96839.82₹96839.82 | 26.30Average 26.3 Average | 9.94%Poor 9.94% Poor | 14.54%Average 14.54% Average | 0.20Excellent 0.2 Excellent | -8.07%Poor -8.07% Poor | 6.32%Good 6.32% Good | 0.26% |
Lupin LimitedLupin Limited... LUPIN • 500257 | 83.4/100 | ₹2100.70₹2101 | ₹96054.51₹96054.51 | 17.36Average 17.4 Average | 26.90%Excellent 26.90% Excellent | 31.80%Excellent 31.80% Excellent | 0.26Excellent 0.3 Excellent | 34.39%Excellent 34.39% Excellent | 13.02%Good 13.02% Good | 0.72% |
Dr. Reddy's Laboratories LimitedDr. Reddy's Lab... DRREDDY • 500124 | 41/100 | ₹1144.50₹1145 | ₹95565.75₹95565.75 | 29.58Average 29.6 Average | 11.75%Average 11.75% Average | 14.80%Average 14.80% Average | 0.17Excellent 0.2 Excellent | 16.54%Excellent 16.54% Excellent | 12.09%Good 12.09% Good | 0.65% |
Mankind Pharma LimitedMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2293.70₹2294 | ₹94729.81₹94729.81 | 46.35Average 46.3 Average | 12.49%Average 12.49% Average | 13.56%Average 13.56% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Limited share price450228.65 Cr
- Divi's Laboratories Limited share price250888.75 Cr
- Torrent Pharmaceuticals Limited share price167182.32 Cr
- Zydus Lifesciences Limited share price113642.26 Cr
- Cipla Limited share price110828.94 Cr
Medi Caps Limited Quarterly Performance
Latest quarterly metrics for MEDICAPQ — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-50.50%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
76.74%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
-26.34%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Medi Caps Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for MEDICAPQ — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Medi Caps Limited Financial Statements
Annual income statement, balance sheet and cash flow for Medi Caps Limited (MEDICAPQ) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Medi Caps Limited
About MEDICAPQ (Medi Caps Limited)
Medi Caps Ltd is a dynamic pharmaceutical company dedicated to advancing healthcare through innovative drug development and manufacturing. With a focus on providing high-quality, a...ffordable medicines, Medi Caps is committed to improving patient outcomes across a range of therapeutic areas. The company’s state-of-the-art facilities adhere to the strictest international regulatory standards, ensuring the safety and efficacy of its products. Medi Caps is actively involved in research and development, constantly seeking new and improved formulations to address unmet medical needs. Their dedication extends beyond product development; they are focused on building strong partnerships with healthcare professionals and distributors to ensure their medications are accessible to those who need them most. Medi Caps operates with a deep commitment to ethical business practices and environmental sustainability. The company strives to minimize its environmental footprint by implementing eco-friendly manufacturing processes and promoting responsible waste management. Furthermore, Medi Caps actively engages with local communities through various initiatives aimed at improving health and well-being. The company believes in fostering a culture of innovation and collaboration, empowering its employees to contribute their expertise and passion to the pursuit of pharmaceutical excellence. They have invested significantly in training and development programs to nurture talent and build a highly skilled workforce capable of driving future growth. Medi Caps Ltd is strategically positioned for continued growth and success in the evolving pharmaceutical landscape. By focusing on innovation, quality, and accessibility, the company is poised to expand its product portfolio and reach new markets. Medi Caps continues to build its brand reputation as a trusted provider of high-quality medications, and is focused on building long-term value for its stakeholders. With a strong leadership team and a dedicated workforce, Medi Caps is well-equipped to meet the challenges and opportunities of the pharmaceutical industry, remaining committed to its mission of improving global health and well-being.
Company Details
Key Leadership
MEDICAPQ Share Price: Frequently Asked Questions
What is the current share price of Medi Caps Limited?
Medi Caps Limited (MEDICAPQ) trades at ₹35.22 on NSE and BSE. Market cap ₹33.49 (Cr). Educational data only.
What is the P/E ratio of Medi Caps Limited?
Medi Caps Limited has a P/E of N/Ax vs industry average 34.89x.
What is the Bull Run score for Medi Caps Limited?
Medi Caps Limited has a Bull Run score of 18.5/100 based on 25+ financial parameters.
Does Medi Caps Limited pay dividends?
Medi Caps Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Medi Caps Limited?
Medi Caps Limited has ROE of -2.61%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Medi Caps Limited?
Medi Caps Limited has debt-to-equity of 0.00.
Is Medi Caps Limited a good investment?
Bull Run gives Medi Caps Limited a score of 18.5/100. This is not investment advice — consult a SEBI-registered advisor.